In vitro-induced response patterns of antileukemic T cells: characterization by spectratyping and immunophenotyping

Reuther S, Schmetzer H, Schuster FR, Krell P, Grabrucker C, Liepert A, Kroell T, Kolb H-J, Borkhardt A, Buhmann R (2013)
Clinical and Experimental Medicine 13(1): 29-48.

Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ; ; ; ; ;
Abstract
Myeloid leukemic cells can be induced to differentiate into leukemia-derived dendritic cells (DC(leu)) regaining the stimulatory capacity of professional DCs while presenting the leukemic antigen repertoire. But so far, the induced antileukemic T-cell responses are variable both in specificity and in efficacy. In an attempt to elucidate the underlying causes of different T-cell response patterns, T-cell receptor (TR) Vβ chain rearrangements were correlated with the T cells corresponding immunophenotypic profile, as well as their proliferative response and cytolytic capacities. In three different settings, donor T cells, either human leukocyte antigen matched or mismatched (haploidentical), or autologous T cells were repeatedly stimulated with myeloid blasts or leukemia-derived DC/DC(leus) from the corresponding patients diseased from acute myeloid leukemia (AML). Although no significant differences in T-cell proliferation were observed, the T-cell-mediated cytolytic response pattern varied considerably and even caused blast proliferation in two cases. Spectratyping revealed a remarkable restriction (>75 % of normal level) of the CD4(+) or CD8(+)-TR repertoire of blast- or DC/DC(leu)-stimulated T cells. Although in absolute terms, DC/DC(leu) stimulation induced the highest grade of restriction in the CD8(+) T-cell subset, the CD4(+) T-cell compartment seemed to be relatively more affected. But most importantly, in vitro stimulation with DC/DC(leu) resulted into an identical TR restriction pattern (β chain) that could be identified in vivo in a patient sample 3 months after allo-SCT. Thus, in vitro tests combining functional flow cytometry with spectratyping might provide predictive information about T cellular response patterns in vivo.
Publishing Year
ISSN
eISSN
PUB-ID

Cite this

Reuther S, Schmetzer H, Schuster FR, et al. In vitro-induced response patterns of antileukemic T cells: characterization by spectratyping and immunophenotyping. Clinical and Experimental Medicine. 2013;13(1):29-48.
Reuther, S., Schmetzer, H., Schuster, F. R., Krell, P., Grabrucker, C., Liepert, A., Kroell, T., et al. (2013). In vitro-induced response patterns of antileukemic T cells: characterization by spectratyping and immunophenotyping. Clinical and Experimental Medicine, 13(1), 29-48.
Reuther, S., Schmetzer, H., Schuster, F. R., Krell, P., Grabrucker, C., Liepert, A., Kroell, T., Kolb, H. - J., Borkhardt, A., and Buhmann, R. (2013). In vitro-induced response patterns of antileukemic T cells: characterization by spectratyping and immunophenotyping. Clinical and Experimental Medicine 13, 29-48.
Reuther, S., et al., 2013. In vitro-induced response patterns of antileukemic T cells: characterization by spectratyping and immunophenotyping. Clinical and Experimental Medicine, 13(1), p 29-48.
S. Reuther, et al., “In vitro-induced response patterns of antileukemic T cells: characterization by spectratyping and immunophenotyping”, Clinical and Experimental Medicine, vol. 13, 2013, pp. 29-48.
Reuther, S., Schmetzer, H., Schuster, F.R., Krell, P., Grabrucker, C., Liepert, A., Kroell, T., Kolb, H.-J., Borkhardt, A., Buhmann, R.: In vitro-induced response patterns of antileukemic T cells: characterization by spectratyping and immunophenotyping. Clinical and Experimental Medicine. 13, 29-48 (2013).
Reuther, Susanne, Schmetzer, Helga, Schuster, Friedhelm R., Krell, Pina, Grabrucker, Christine, Liepert, Anja, Kroell, Tanja, Kolb, Hans-Jochem, Borkhardt, Arndt, and Buhmann, Raymund. “In vitro-induced response patterns of antileukemic T cells: characterization by spectratyping and immunophenotyping”. Clinical and Experimental Medicine 13.1 (2013): 29-48.
This data publication is cited in the following publications:
This publication cites the following data publications:

1 Citation in Europe PMC

Data provided by Europe PubMed Central.

Tracking global changes induced in the CD4 T-cell receptor repertoire by immunization with a complex antigen using short stretches of CDR3 protein sequence.
Thomas N, Best K, Cinelli M, Reich-Zeliger S, Gal H, Shifrut E, Madi A, Friedman N, Shawe-Taylor J, Chain B., Bioinformatics 30(22), 2014
PMID: 25095879

44 References

Data provided by Europe PubMed Central.


AUTHOR UNKNOWN, 1995
Improved effector function of leukemia-specific T-lymphocyte clones trained with AML-derived dendritic cells.
Schuster FR, Buhmann R, Reuther S, Hubner B, Grabrucker C, Liepert A, Reibke R, Lichtner P, Yang T, Kroell T, Kolb HJ, Borkhardt A, Schmetzer H., Cancer Genomics Proteomics 5(5), 2008
PMID: 19129558
Progressive differentiation and selection of the fittest in the immune response.
Lanzavecchia A, Sallusto F., Nat. Rev. Immunol. 2(12), 2002
PMID: 12461571

XD, J Immunol Methods 275(1–2), 2003
The fluorolysis assay, a highly sensitive method for measuring the cytolytic activity of T cells at very low numbers.
Kienzle N, Olver S, Buttigieg K, Kelso A., J. Immunol. Methods 267(2), 2002
PMID: 12165431
Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions.
Kufner S, Zitzelsberger H, Kroell T, Pelka-Fleischer R, Salem A, de Valle F, Schweiger C, Nuessler V, Schmid C, Kolb HJ, Schmetzer HM., Scand. J. Immunol. 62(1), 2005
PMID: 16091128
Oligoclonality of CD8+ T cells in multiple sclerosis.
Monteiro J, Hingorani R, Peroglizzi R, Apatoff B, Gregersen PK., Autoimmunity 23(2), 1996
PMID: 8871768
Oligoclonality of tumor-infiltrating lymphocytes from human melanomas.
Puisieux I, Even J, Pannetier C, Jotereau F, Favrot M, Kourilsky P., J. Immunol. 153(6), 1994
PMID: 8077684
Analysis of T-cell repertoire in hepatitis-associated aplastic anemia.
Lu J, Basu A, Melenhorst JJ, Young NS, Brown KE., Blood 103(12), 2004
PMID: 14988156

AUTHOR UNKNOWN, 0
Contributions of CD4+, CD8+, and CD4+CD8+ T cells to skewing within the peripheral T cell receptor beta chain repertoire of healthy macaques.
Currier JR, Stevenson KS, Kehn PJ, Zheng K, Hirsch VM, Robinson MA., Hum. Immunol. 60(3), 1999
PMID: 10321957

H, Bone Marrow Transpl 39(1), 2007
Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.
Childs R, Chernoff A, Contentin N, Bahceci E, Schrump D, Leitman S, Read EJ, Tisdale J, Dunbar C, Linehan WM, Young NS, Barrett AJ., N. Engl. J. Med. 343(11), 2000
PMID: 10984562
CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation.
Giralt S, Hester J, Huh Y, Hirsch-Ginsberg C, Rondon G, Seong D, Lee M, Gajewski J, Van Besien K, Khouri I, Mehra R, Przepiorka D, Korbling M, Talpaz M, Kantarjian H, Fischer H, Deisseroth A, Champlin R., Blood 86(11), 1995
PMID: 7492795
Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells.
Zorn E, Wang KS, Hochberg EP, Canning C, Alyea EP, Soiffer RJ, Ritz J., Clin. Cancer Res. 8(7), 2002
PMID: 12114403
Resurrecting CD8+ suppressor T cells.
Chess L, Jiang H., Nat. Immunol. 5(5), 2004
PMID: 15116110
Regulation of immune responses by T cells.
Jiang H, Chess L., N. Engl. J. Med. 354(11), 2006
PMID: 16540617
Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencing.
Freeman JD, Warren RL, Webb JR, Nelson BH, Holt RA., Genome Res. 19(10), 2009
PMID: 19541912

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 22441559
PubMed | Europe PMC

Search this title in

Google Scholar